✦ LIBER ✦

Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor–2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study

✍ Scribed by Vaz-Luis, Ines; Seah, Davinia; Olson, Erin M.; Wagle, Nikhil; Metzger-Filho, Otto; Sohl, Jessica; Litsas, Georgia; Burstein, Harold J.; Krop, Ian E.; Winer, Eric P.; Lin, Nancy U.

Book ID: 120529931
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 652 KB
Volume: 13
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2013.02.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pertuzumab Monotherapy After Trastuzumab

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

✍ Cortes, J.; Fumoleau, P.; Bianchi, G. V.; Petrella, T. M.; Gelmon, K.; Pivot, X. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 497 KB

Overall Survival Benefit With Lapatinib

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

✍ Blackwell, K. L.; Burstein, H. J.; Storniolo, A. M.; Rugo, H. S.; Sledge, G.; Ak 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 203 KB

Impact of hormone receptor status on pat

Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study

✍ Ines Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, P Kelly Marcom, Beverly Moy, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 377 KB